Company Filing History:
Years Active: 2017-2018
Title: Innovator Spotlight: Matthew T. Duvernay
Introduction: Matthew T. Duvernay, based in Nashville, TN, is a notable inventor in the field of biomedical research. With a focus on thrombotic disorders, Duvernay has made significant contributions to the development of innovative compounds that target crucial biological pathways. His work centers around creating antagonists for protease activated receptor-4 (PAR-4), which plays a vital role in various diseases.
Latest Patents: Duvernay holds two innovative patents that showcase his expertise. The first patent, titled "Substituted 5-membered heterocyclic analogs as protease activated receptor 4 (PAR-4) antagonists," emphasizes the development of compounds designed to inhibit PAR-4. This invention includes methods of preparation and highlights the potential for treating diseases related to thrombotic disorders through the administration of these compositions. The second patent, "Substituted indoles as selective protease activated receptor 4 (PAR-4) antagonists," further expands on this theme by introducing substituted indole compounds aimed at the same receptor. The described methods of preparation and treatment options illustrate the continued advancements in therapeutic innovations spearheaded by Duvernay.
Career Highlights: Matthew T. Duvernay currently works at Vanderbilt University, where he engages in cutting-edge research. His tenure at this prestigious institution has allowed him to explore various facets of biomedical science and to promote the translation of basic research into practical applications.
Collaborations: Throughout his career, Duvernay has collaborated with esteemed colleagues such as Heidi E. Hamm and Shaun R. Stauffer. These partnerships have led to substantial advancements in understanding the mechanisms of thrombotic disorders and developing new therapeutic options.
Conclusion: With a clear impact on the field of biomedical research, Matthew T. Duvernay exemplifies the role of innovation in addressing significant health challenges. His patents highlight the importance of advancing knowledge and technology in the pursuit of effective treatments for thrombotic disorders. Through his work at Vanderbilt University and collaborations with fellow researchers, Duvernay continues to contribute significantly to the landscape of medical science.